Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Dexcom (DXCM) Profit After Tax (2016 - 2025)

Historic Profit After Tax for Dexcom (DXCM) over the last 17 years, with Q4 2025 value amounting to $267.3 million.

  • Dexcom's Profit After Tax rose 7620.3% to $267.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $836.3 million, marking a year-over-year increase of 4514.06%. This contributed to the annual value of $836.3 million for FY2025, which is 4514.06% up from last year.
  • Per Dexcom's latest filing, its Profit After Tax stood at $267.3 million for Q4 2025, which was up 7620.3% from $283.8 million recorded in Q3 2025.
  • In the past 5 years, Dexcom's Profit After Tax registered a high of $283.8 million during Q3 2025, and its lowest value of -$5.3 million during Q4 2021.
  • Moreover, its 5-year median value for Profit After Tax was $110.6 million (2023), whereas its average is $125.6 million.
  • As far as peak fluctuations go, Dexcom's Profit After Tax crashed by 10128.86% in 2021, and later soared by 183207.55% in 2022.
  • Dexcom's Profit After Tax (Quarter) stood at -$5.3 million in 2021, then skyrocketed by 1832.08% to $91.8 million in 2022, then skyrocketed by 179.19% to $256.3 million in 2023, then tumbled by 40.81% to $151.7 million in 2024, then soared by 76.2% to $267.3 million in 2025.
  • Its Profit After Tax was $267.3 million in Q4 2025, compared to $283.8 million in Q3 2025 and $179.8 million in Q2 2025.